Ontario-based Cronos Group reported quarterly revenue of 12.7 million Canadian dollars ($9.6 million), an improvement over the previous quarter's CA$10.2 million but slightly lower than consensus estimates. The cannabinoid company's adjusted EBITDA loss widened quarter-over-quarter to CA$24 million. However, most of the company's sales came in the licensed producer-to-licensed producer market. Cronos also announced the conversion of some cultivation space to allow for the production and sale ...
Browse Article Categories
Cronos to convert some cultivation space, reports revenue growth
Rate this article
No Comments Yet
Be the first to share what you think!